Last updated: May 1, 2026, 6:07 am
PSMO-07 - 59 - Financial toxicity: Pharmacy interventions that save health and well-being
Tracks
Track 3
| Monday, August 31, 2026 |
| 2:30 PM - 4:00 PM |
Details
Organised by the FIP Academic Pharmacy Section in collaboration with the FIP Social and Administrative Pharmacy Section and the FIP Ethics Advisory Group
Chair(s)
Dr Certina Ho, Exexcutive Committee Member, the FIP Social and Administrative Pharmacy Section, Canada & Dr Carl Schneider, Secretary, the FIP Academic Pharmacy Section, Australia
Introduction:
Financial toxicity, the profound material and psychological burden imposed by healthcare costs, affects many patients with chronic conditions, resulting in medication non-adherence. Financial toxicity is a system-level challenge requiring collaboration between patients, pharmacists, prescribers, payers, policymakers, and community organisations, rather than an individual failure of adherence or motivation. Yet financial barriers remain systematically under-addressed in routine pharmaceutical care. The session will focus on practical, pharmacy-led actions and care models, rather than broader drug pricing or reimbursement policy debates beyond the scope of professional practice.
Programme:
Learning objectives:
1. Gain knowledge of the impact of financial costs towards the inequitable access to care.
2. Learn to conduct structured cost conversations during patient counselling using validated frameworks.
3. Understand the need to navigate complex assistance programmes, referral pathways, and advocacy channels for medication affordability.
Take home messages:
Pharmacists, as the most accessible health professionals, play a key role in equitable care. Using cost-conversation scripts integrated into routine counselling, they can help patients to navigate financial challenges. Pharmacists need also to advocate for policies that promote fairness and improve patient access to essential medicines and services.
FIP Development Goals:
To learn more about these FIP Development Goals, click on the links below.
FIP Development Goal 10: Equity and Equality
FIP Development Goal 11: Impact and Outcomes
FIP Development Goal 18: Access to Medicines, Devices & Services
| 14:30 – 14:40 | Introduction by the chairs |
| 14:40 – 15:00 | Financial toxicity in high-cost pharmacotherapy and evidence-based intervention strategies |
| Dr Joelle Farano, U.S. Department of Veterans Affairs, USA | |
| 15:00 – 15:20 | Educating for equity: Preparing pharmacists to address financial toxicity through curriculum |
| Dr Antonius Pratama, Universitas Jember, Indonesia | |
| 15:20 – 15:50 | Panel discussion with chairs, speakers and additional panellists |
| 15:50 – 16:00 | Closing remarks by the chairs |
Chairs & speakers
Dr Certina Ho
Executive Committee Member
Social & Administrative Pharmacy Section (SAPS)
Chairing of 59 - Financial toxicity: Pharmacy interventions that save health and well-being
Dr Carl Schneider
Secretary
FIP Academic Pharmacy Section
Chairing of 59 - Financial toxicity: Pharmacy interventions that save health and well-being
Dr Joelle Farano
U.S. Department of Veterans Affairs
Financial toxicity in high-cost pharmacotherapy and evidence-based intervention strategies
Dr Antonius Pratama
Universitas Jember
Educating for equity: Preparing pharmacists to address financial toxicity through curriculum
